Funding · Healthcare & Life Sciences

DUSQ raises ₹24 crore seed funding from Fireside Ventures

By Startup Enthusiast · 12 February 2026

What they do

DUSQ is a sleep science and recovery company based in Delhi NCR

The company raised ₹24 crore in seed funding led by Fireside Ventures

Funds will support US launch and expansion of neuroscience and hardware teams

Indian startup DUSQ has raised ₹24 crore in seed funding.
The round was led by Fireside Ventures with participation from several other investors.
Previous pre-seed funding of ₹6.5 crore was raised in April 2025.
Angel investors include Avnish Anand and Shivam Puri.
The company plans to use funds for its US launch around March 2026.
DUSQ focuses on biological regulation rather than just sleep tracking.
The startup previously operated as InnerGize before rebranding to DUSQ.
It gained visibility through an appearance on Shark Tank India.

The global sleep tech market is currently dominated by US and European players.
There is a shift in the industry from optimization to restoration.
The company leverages over 50 million data points from two years of research.

DUSQ uses adhesive wearables applied behind the ear for vagus nerve stimulation.
Smart sensors are used to gather data and gauge physiological responses.
The core hypothesis is that sleep failure is driven by brain-body desynchrony.
Recovery requires biological regulation rather than simple tracking or optimization.
The company maintains an in-house sleep lab for testing and development.
DUSQ operates under a regulation-first approach to sleep technology.
The company analyzes physiological data to inform its hardware design.

Product: Wearable device for sleep regulation combining neuroscience and hardware design with stick-on and wearable formats
Customers: Consumers seeking improved sleep quality and neuroscience-backed sleep regulation
How it makes money: Direct-to-consumer sales of wearable devices and sleep regulation platform
What sets it apart: Proprietary sleep laboratory for testing and development; backed by 50+ million physiological data points
Operations: Research-backed product development with structured clinical trials in in-house sleep laboratory